Local Control Rates of Metastatic Renal Cell Carcinoma (RCC) to the Bone Using Stereotactic Body Radiation Therapy: Is RCC Truly Radioresistant?

Practical Radiation Oncology - Netherlands
doi 10.1016/j.prro.2015.05.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Prognostic Factors of Local Control, Overall Survival, and Toxicity

PLoS ONE
Multidisciplinary
2013English

Establishment and Characterization of a Cell Line (Ko-RCC-1) From a Human Renal Cell Carcinoma

Japanese Journal of Urology
Urology
1986English

Sunitinib Induced Cytopenia in Metastatic RCC

Clinical Medical Reviews and Case Reports
2018English

Pd48-01 the Impact of Perioperative Blood Transfusion on Cancer Recurrence and Survival Following Nephrectomy for Non-Metastatic Renal Cell Carcinoma (Rcc).

Journal of Urology
Urology
2016English

Phase 1 Trial of Allogeneic Gene-Modified Tumor Cell Vaccine RCC-26/CD80/IL-2 in Patients With Metastatic Renal Cell Carcinoma

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2010English

Brain Complete Response to Cabozantinib Prior to Radiation Therapy in Metastatic Renal Cell Carcinoma

Case Reports in Urology
2019English

A Comparison of Radiologic Tumor Volume and Pathologic Tumor Volume in Renal Cell Carcinoma (RCC)

PLoS ONE
Multidisciplinary
2015English

Tailoring Immunotherapy Treatment of Synchronous Renal Cell Carcinoma (RCC) and Triple-Negative Breast Cancer (TNBC)

Case Reports in Oncological Medicine
Oncology
2019English

Stereotactic Radiation Therapy for Renal Cell Carcinoma Metastases: A Meta-Analysis of 28 Studies

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy